Scinai Immunotherapeutics Ltd. (SCNI)
SCNI Stock Price Chart
Explore Scinai Immunotherapeutics Ltd. interactive price chart. Choose custom timeframes to analyze SCNI price movements and trends.
SCNI Company Profile
Discover essential business fundamentals and corporate details for Scinai Immunotherapeutics Ltd. (SCNI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
11 May 2015
Employees
31.00
Website
https://www.scinai.comCEO
Amir Reichman
Description
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
SCNI Financial Timeline
Browse a chronological timeline of Scinai Immunotherapeutics Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 28 Aug 2025
EPS came in at -$3.57 .
Earnings released on 30 May 2025
EPS came in at -$0.00 , while revenue for the quarter reached $158.00K .
Earnings released on 7 May 2025
EPS came in at -$10.40 , while revenue for the quarter reached $56.54K .
Earnings released on 22 Nov 2024
EPS came in at $8.40 , while revenue for the quarter reached $44.21K .
Earnings released on 15 Aug 2024
EPS came in at -$3.57 , while revenue for the quarter reached $75.41K .
Earnings released on 2 Jul 2024
EPS came in at -$4.00 .
Stock split effective on 21 May 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2024
EPS came in at -$240.00 falling short of the estimated -$0.62 by -38.61K%.
Earnings released on 31 Oct 2023
EPS came in at -$6.60 falling short of the estimated -$0.99 by -566.67%.
Earnings released on 11 Aug 2023
EPS came in at -$1.11 falling short of the estimated -$0.91 by -21.98%.
Earnings released on 15 May 2023
EPS came in at -$1.20 surpassing the estimated -$22.00 by +94.55%.
Earnings released on 17 Apr 2023
EPS came in at -$0.30 .
Stock split effective on 25 Nov 2022
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2022
EPS came in at $0.00 surpassing the estimated -$1.00 by +100.04%.
Earnings released on 30 Jun 2022
EPS came in at -$0.00 surpassing the estimated -$1.00 by +99.89%.
Earnings released on 31 Mar 2022
EPS came in at -$0.00 .
Earnings released on 31 Dec 2021
EPS came in at $0.00 .
Earnings released on 30 Sept 2021
EPS came in at -$0.00 .
Earnings released on 30 Jun 2021
EPS came in at -$0.00 .
Earnings released on 31 Mar 2021
EPS came in at -$0.00 .
Earnings released on 31 Dec 2020
EPS came in at -$0.00 .
Earnings released on 30 Sept 2020
EPS came in at $0.01 .
SCNI Stock Performance
Access detailed SCNI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.